CMR Surgical, a Cambridge, UK-based developer of surgical robotics, raised $165m in funding.
Backers included SoftBank, Ally Bridge Group, Cambridge Innovation Capital, Escala Capital, LGT, Lightrock, RPMI Railpen, Tencent and Watrium.
The company intends to use the funds for continued product innovation, including new technological developments, and further commercialisation of the system in key existing, and new, geographies.
Led by Supratim Bose, Chief Executive Officer, CMR Surgical provides a surgical robotic system called Versius®, which gained CE approval in 2019, and today, more than 140 systems have been installed in hospitals around the world across the UK, Europe, Latin America, the Middle East, Asia and Africa. The system has been used to perform more than 15,000 procedures globally. The 15,000 surgeries have been performed in a range of differently sized hospitals, including globally-renowned research hospitals such as Royal Papworth Hospital NHS Foundation Trust (UK), Institute Curie (France), Policlinico di Milano (Italy), Max Super Specialty Hospital (India), the Sindh Institute of Urology and Transplantation (SIUT) (Pakistan), Hospital Moinhos de Vento (Brazil), Gleneagles Hospital (Hong Kong) and Klinikum Chemnitz GmbH (Germany). The cases span more than 130 complex and benign procedure types including colectomies, hernia repairs, hysterectomies, sacrocolpopexies, and lobectomies across seven surgical specialties.
FinSMEs
21/09/2023